
|Articles|April 28, 2003
New BPH guidelines endorse combination drug therapy for select patients
>ChicagoCombination drug therapy for benign prostatic hyperplasiahas won the endorsement of the American Urological Association in the organization'sfirst-ever clinical guidelines for the management of BPH.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











